Gufic Biosciences Q3 Result 2024: Date and Time, Share Price and Target

News: Gufic Biosciences, a prominent player in the pharmaceutical industry, is all set to unveil its third-quarter results for the year 2024. Investors and stakeholders eagerly await this financial update to gauge the company’s performance. In this article, we’ll delve into the key aspects of Gufic Biosciences’ Q3 results, including the date and time of the announcement, share price movements, and potential targets.

1. Date and Time of Announcement

The company has scheduled its board meeting to discuss the Q3 results on February 14, 2024. During this meeting, Gufic Biosciences will present its financial performance for the quarter ended December 31, 2023. Investors should mark their calendars and keep an eye out for any significant announcements during this session.

2. Share Price Insights

As of the last trading session, Gufic Biosciences’ share price stood at Rs 324.95 on the National Stock Exchange (NSE). The stock witnessed a 1.85% decline from its previous closing price of Rs 331.05. While short-term fluctuations are common, investors should closely monitor the share price movement after the Q3 results are disclosed.

Key Metrics:

• PE Ratio: 39.61 (Price-to-Earnings ratio)
• EPS (TTM): ₹8.20 (Earnings per Share, trailing twelve months)
• Market Cap: ₹3,258.52 crore
• Dividend Yield: 0.03%
• Beta: 1.23 (indicating moderate volatility)

3. What to Expect?

Investors and analysts will focus on several aspects during the Q3 results presentation:

• Revenue Growth: Gufic Biosciences faced a revenue contraction of 11.39% in the previous quarter. Will this trend continue, or will there be signs of recovery?
• Contingent Liabilities: The company’s cash reserves are crucial for handling any unforeseen liabilities. Investors will assess the coverage of contingent liabilities.
• Employee and Interest Expenses: Understanding the company’s cost structure is essential. Gufic Biosciences allocated 12.56% of its operating revenues to employee costs and 1.19% to interest expenses in the last fiscal year.

4. Target Price Projection

While we don’t have a crystal ball, analysts estimate a target price range for Gufic Biosciences. For 2024, the stock price target varies between ₹366.7 (downside) and ₹390.7 (upside). Keep in mind that these projections are based on the company’s expected future earnings.

Subscribe to Sarkari Result to stay informed. Get the latest celebrity news and detailed movie reviews in real-time. Keep up with the constantly changing world of entertainment with Sarkari Exam.

About Gufic Biosciences :

Gufic Biosciences: A Pillar in Pharmaceutical Innovation

Since 1970, Gufic Biosciences has been a stalwart in the pharmaceutical industry, earning respect for its innovative and high-quality pharmaceutical and herbal products. Let’s delve into the essence of this remarkable company:

1. A Legacy of Excellence

• Founding Year: Established in 1984, Gufic Biosciences has consistently delivered active pharmaceutical ingredients (APIs) for various applications.
• Global Reach: The company markets its products not only in India but also across the Americas, Australia, and other parts of Asia.

2. Core Offerings

Gufic Biosciences specializes in:

• Lyophilized Injections: As one of India’s largest manufacturers of lyophilized injections, Gufic produces a wide range of lyophilized products. These include segments such as antibiotics, antifungals, cardiac medications, infertility treatments, antivirals, and proton-pump inhibitors.
• Herbal and Pharmaceutical Products: Gufic’s portfolio extends to herbal and pharmaceutical formulations, emphasizing quality and efficacy.

As Gufic Biosciences prepares to reveal its Q3 results, investors should stay informed and analyze the financial data carefully. Whether you’re a seasoned investor or a curious observer, this announcement provides valuable insights into the company’s health and prospects. Watch out for updates on February 14, 2024, and make informed decisions based on the facts presented.

Disclaimer: Please note that all content and tools on this website are provided for your convenience and are offered “as is” without warranties. The information provided, including any tool-generated output, is for informational purposes only and should not be considered investment advice or guarantees. Exercise caution, seek professional advice, and make independent judgments before acting on any information found on this site.